keyword drug-costs 
World of DTC Marketing
AUGUST 16, 2020
I have seen first hand how the drugs we market can save lives and lead to a better quality of life for millions. When I first started in the industry DTC was fairly new as we launched a number of groundbreaking drugs such as statins. I am critical because I love this industry. Slowly I saw a change within companies.
World of DTC Marketing
FEBRUARY 7, 2021
Drug Discovery and Manufacturing: It helps in the initial screening of drug compounds to the predicted success rate based on biological factors. Precision medicine or next-generation sequencing helps in the faster discovery of drugs and tailored medication for individual patients. . Measuring RNA, DNA quickly.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Rethinking Clinical Trials
OCTOBER 26, 2023
There is high cost of treatment and insurance prior-authorization requirements. with the rate of reported acute Hepatitis C cases increasing 400% during 2010-2020. Many people do not know they have Hepatitis C (about 40% of patients). There is a lack of point-of-care diagnostics; it can take up to 3 steps to treatment initiation.
pharmaphorum
NOVEMBER 13, 2020
Each country has different regulations in regard to the online advertising of prescription drugs and over-the-counter medicines. Ensure keywords used are relevant for your audience – medical terminology for professionals and informational keywords providing solutions to ailments for consumers.
Rethinking Clinical Trials
AUGUST 28, 2023
 Speakers Prof Sir Martin Landray, FMedSci Professor of Medicine & Epidemiology University of Oxford Chief Executive, Protas Khair ElZarrad, PhD, MPH Director, Office of Medical Policy Center for Drug Evaluation and Research (CDER) U.S.
Rethinking Clinical Trials
AUGUST 28, 2023
 Speakers Prof Sir Martin Landray, FMedSci Professor of Medicine & Epidemiology University of Oxford Chief Executive, Protas Khair ElZarrad, PhD, MPH Director, Office of Medical Policy Center for Drug Evaluation and Research (CDER) U.S.
Roots Analysis
NOVEMBER 3, 2023
NAMPT inhibitors are a class of drugs that target the enzyme nicotinamide phosphoribosyltransferase (NAMPT). One of the main challenges is the development of drug resistance, as cancer cells can develop mechanisms to bypass the inhibition of NAMPT. Several trials focused on evaluation of such drugs were discontinued in the past.
Expert insights. Personalized for you.
196 
Let's personalize your content